• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SAMMPRIS试验中危险因素控制与血管事件的关系。

Relationship between risk factor control and vascular events in the SAMMPRIS trial.

作者信息

Turan Tanya N, Nizam Azhar, Lynn Michael J, Egan Brent M, Le Ngoc-Anh, Lopes-Virella Maria F, Hermayer Kathie L, Harrell Jamie, Derdeyn Colin P, Fiorella David, Janis L Scott, Lane Bethany, Montgomery Jean, Chimowitz Marc I

机构信息

From Medical University of South Carolina (T.N.T., M.F.L.-V., K.L.H., J.H., M.I.C.), Charleston; Emory University (A.N., M.J.L., B.L., J.M.), Atlanta, GA; University of South Carolina School of Medicine (B.M.E.), Greenville; Atlanta VAMC (N.-A.L.), Decatur, GA; Washington University (C.P.D.), St. Louis, MI; State University of New York at Stony Brook (D.F.); and National Institute of Neurological Disorders and Stroke (L.S.J.), Bethesda, MD.

出版信息

Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.

DOI:10.1212/WNL.0000000000003534
PMID:28003500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5272964/
Abstract

OBJECTIVE

The Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) study is the first stroke prevention trial to include protocol-driven intensive management of multiple risk factors. In this prespecified analysis, we aimed to investigate the relationship between risk factor control during follow-up and outcome of patients in the medical arm of SAMMPRIS.

METHODS

Data from SAMMPRIS participants in the medical arm (n = 227) were analyzed. Risk factors were recorded at baseline, 30 days, 4 months, and then every 4 months for a mean follow-up of 32 months. For each patient, values for all risk factor measures were averaged and dichotomized as in or out of target.

RESULTS

Participants who were out of target for systolic blood pressure and physical activity, as well as those with higher mean low-density lipoprotein cholesterol and non-high-density lipoprotein, were more likely to have a recurrent vascular event (stroke, myocardial infarction, or vascular death) at 3 years compared to those who had good risk factor control. In the multivariable analysis, greater physical activity decreased the likelihood of a recurrent stroke, myocardial infarction, or vascular death (odds ratio 0.6, confidence interval 0.4-0.8).

CONCLUSIONS

Raised blood pressure, cholesterol, and physical inactivity should be aggressively treated in patients with intracranial atherosclerosis to prevent future vascular events. Physical activity, which has not received attention in stroke prevention trials, was the strongest predictor of a good outcome in the medical arm in SAMMPRIS.

CLINICALTRIALSGOV IDENTIFIER

NCT00576693.

摘要

目的

颅内狭窄支架置入与积极药物预防复发性卒中(SAMMPRIS)研究是首个纳入对多种危险因素进行方案驱动的强化管理的卒中预防试验。在这项预先设定的分析中,我们旨在研究SAMMPRIS药物治疗组患者随访期间危险因素控制与预后之间的关系。

方法

对SAMMPRIS药物治疗组的参与者(n = 227)的数据进行分析。在基线、30天、4个月时记录危险因素,然后每4个月记录一次,平均随访32个月。对于每位患者,将所有危险因素测量值进行平均,并按照是否达到目标分为两类。

结果

与危险因素控制良好的患者相比,收缩压、体力活动未达目标的参与者,以及平均低密度脂蛋白胆固醇和非高密度脂蛋白水平较高的参与者在3年时更有可能发生复发性血管事件(卒中、心肌梗死或血管性死亡)。在多变量分析中,更多的体力活动降低了复发性卒中、心肌梗死或血管性死亡的可能性(比值比0.6,置信区间0.4 - 0.8)。

结论

对于颅内动脉粥样硬化患者,应积极治疗血压升高、胆固醇升高和缺乏体力活动的情况,以预防未来的血管事件。体力活动在卒中预防试验中未受到关注,却是SAMMPRIS药物治疗组良好预后的最强预测因素。

临床试验注册号

NCT00576693。

相似文献

1
Relationship between risk factor control and vascular events in the SAMMPRIS trial.SAMMPRIS试验中危险因素控制与血管事件的关系。
Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.
2
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.SAMMPRIS试验医疗组中复发性缺血性卒中的相关因素。
JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315.
3
Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.颅内狭窄支架置入强化药物治疗预防复发性卒中试验中危险因素控制与生活方式改变计划依从性之间的关系
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.
4
Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.并存小血管疾病和颅内动脉狭窄的频率、危险因素及转归:颅内狭窄支架置入和积极药物治疗预防复发性卒中(SAMMPRIS)试验结果
JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.
5
Impact of Baseline Features and Risk Factor Control on Cognitive Function in the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.支架置入术和强化药物治疗预防颅内狭窄患者卒中复发试验中基线特征和危险因素控制对认知功能的影响。
Cerebrovasc Dis. 2019;47(1-2):24-31. doi: 10.1159/000497245. Epub 2019 Feb 14.
6
Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).颅内支架置入术治疗颅内狭窄患者的围手术期卒中的详细分析——支架置入与强化药物治疗预防颅内狭窄患者卒中复发研究(SAMMPRIS)。
Stroke. 2012 Oct;43(10):2682-8. doi: 10.1161/STROKEAHA.112.661173. Epub 2012 Sep 13.
7
Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).SAMMPRIS试验(颅内狭窄支架置入与积极药物治疗预防复发性卒中)中颅内血管成形术和支架置入术后的非手术性症状性梗死和支架内再狭窄
Stroke. 2017 Jun;48(6):1501-1506. doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.
8
Ameliorating Racial Disparities in Vascular Risk Factor Management With Aggressive Medical Management in the SAMMPRIS Trial.在 SAMMPRIS 试验中通过强化药物治疗改善血管风险因素管理中的种族差异。
Stroke. 2023 Sep;54(9):2235-2240. doi: 10.1161/STROKEAHA.122.042055. Epub 2023 Aug 3.
9
Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.美国心脏协会/美国中风协会中风新定义对颅内狭窄支架置入与积极药物治疗预防复发性中风试验结果的影响
J Stroke Cerebrovasc Dis. 2017 Jan;26(1):108-115. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.038. Epub 2016 Oct 17.
10
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.高风险颅内动脉狭窄患者(SAMMPRIS)强化药物治疗联合或不联合支架置入的疗效:一项随机试验的最终结果。
Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

引用本文的文献

1
Association between walking space and physical activity for hospitalized patients with stroke: a cross-sectional study.住院中风患者的步行空间与身体活动之间的关联:一项横断面研究。
J Phys Ther Sci. 2025 Sep;37(9):486-492. doi: 10.1589/jpts.37.486. Epub 2025 Sep 1.
2
Expression profiles and potential clinical significance of circular RNAs in peripheral neutrophils of patients with intracranial atherosclerotic stenosis.颅内动脉粥样硬化狭窄患者外周血中性粒细胞中环状RNA的表达谱及潜在临床意义
Brain Circ. 2025 Jul 3;11(3):200-211. doi: 10.4103/bc.bc_16_24. eCollection 2025 Jul-Sep.
3
Aerobic minutes and step number remain low in inpatient stroke rehabilitation.在住院卒中康复中,有氧运动分钟数和步数仍然较低。
PLoS One. 2025 Jul 28;20(7):e0328930. doi: 10.1371/journal.pone.0328930. eCollection 2025.
4
Transthoracic Echocardiogram Guided Hemodynamic Management to Maintain Cerebral Perfusion in an Extracranial-Intracranial Bypass Case: Case Report.经胸超声心动图引导血流动力学管理以维持颅外-颅内旁路手术病例中的脑灌注:病例报告
J Neurol Surg Rep. 2025 Jul 22;86(3):e165-e169. doi: 10.1055/a-2650-6679. eCollection 2025 Jul.
5
Evaluating the Usability of Inertial Measurement Units for Measuring and Monitoring Activity Post-Stroke: A Scoping Review.评估惯性测量单元在中风后活动测量与监测中的可用性:一项范围综述
Sensors (Basel). 2025 Jun 12;25(12):3694. doi: 10.3390/s25123694.
6
Relationship Between Fear of Movement and Physical Activity in Patients With Cardiac, Rheumatologic, Neurologic, Pulmonary, or Pain Conditions: A Systematic Review and Meta-Analysis.心脏、风湿、神经、肺部疾病或疼痛疾病患者运动恐惧与身体活动之间的关系:一项系统评价和荟萃分析
Phys Ther. 2025 Jun 2;105(6). doi: 10.1093/ptj/pzaf050.
7
The Potential of Chronic Remote Ischemic Conditioning in Cerebral Small Vessel Disease.慢性远程缺血预处理在脑小血管病中的潜力
Cond Med. 2024 Feb;7(1):6-10.
8
Higher Time to Peak after Stent Implantation in Symptomatic High-Grade Intracranial Atherosclerotic Stenosis is Related to In-Stent Restenosis.症状性重度颅内动脉粥样硬化狭窄患者支架植入术后达到峰值时间延长与支架内再狭窄有关。
Transl Stroke Res. 2025 Mar 22. doi: 10.1007/s12975-025-01346-0.
9
Intracranial Atherosclerotic Stenosis.颅内动脉粥样硬化性狭窄
Cerebrovasc Dis Extra. 2025;15(1):62-67. doi: 10.1159/000543356. Epub 2025 Jan 2.
10
Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis.药物洗脱支架与裸金属支架治疗颅内动脉粥样硬化狭窄:一项系统评价和荟萃分析。
BMJ Open. 2024 Dec 5;14(12):e085533. doi: 10.1136/bmjopen-2024-085533.

本文引用的文献

1
Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.颅内狭窄支架置入强化药物治疗预防复发性卒中试验中危险因素控制与生活方式改变计划依从性之间的关系
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.
2
Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association.身体活动和锻炼对脑卒中幸存者的推荐:美国心脏协会/美国卒中协会发布的一份针对医疗保健专业人员的声明。
Stroke. 2014 Aug;45(8):2532-53. doi: 10.1161/STR.0000000000000022. Epub 2014 May 20.
3
Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia.血压降低与血流动力学性脑缺血中的脑卒中风险降低有关。
Neurology. 2014 Mar 25;82(12):1027-32. doi: 10.1212/WNL.0000000000000238. Epub 2014 Feb 14.
4
Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study.运动和药物干预对死亡率结局的比较效果:荟萃流行病学研究。
BMJ. 2013 Oct 1;347:f5577. doi: 10.1136/bmj.f5577.
5
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.高风险颅内动脉狭窄患者(SAMMPRIS)强化药物治疗联合或不联合支架置入的疗效:一项随机试验的最终结果。
Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.
6
Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.对阿布-谢布尔和斯坦梅茨对颅内狭窄支架置入与积极药物治疗预防复发性卒中(SAMMPRIS)试验的批评的回应。
Stroke. 2012 Oct;43(10):2806-9. doi: 10.1161/strokeaha.112.661041.
7
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.颅内狭窄支架置入与积极药物治疗预防复发性卒中(SAMMPRIS)试验中积极危险因素管理的原理、设计与实施
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. doi: 10.1161/CIRCOUTCOMES.112.966911.
8
Physical activity and risk of cardiovascular disease--a meta-analysis of prospective cohort studies.身体活动与心血管疾病风险——前瞻性队列研究的荟萃分析。
Int J Environ Res Public Health. 2012 Feb;9(2):391-407. doi: 10.3390/ijerph9020391. Epub 2012 Jan 26.
9
Stenting versus aggressive medical therapy for intracranial arterial stenosis.颅内动脉狭窄的血管内支架置入与积极药物治疗的比较。
N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7.
10
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.颅内狭窄患者支架置入和强化药物治疗预防卒中复发试验的设计。
J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):357-68. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.001.